Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Sascha DublinAbisola IduLyndsay A AvalosT Craig CheethamThomas R EasterlingLu ChenVictoria L HoltNerissa NanceZoe Bider-CanfieldRomain S NeugebauerKristi L ReynoldsSylvia E BadonSusan M ShortreedPublished in: PloS one (2022)
Risk of most outcomes was similar comparing labetalol, methyldopa and nifedipine. Risk of the infant being small for gestational age was substantially lower for methyldopa, suggesting this medication may warrant further consideration.